Newly identified personalized immunotherapy combination treats an aggressive form of advanced prostate cancer
Immunotherapies have been successful in treating many cancer conditions; however, not much success has yet been achieved in metastatic castrate-resistant prostate cancer (mCRPC). A study published March 2 in Clinical Cancer ...
Mar 3, 2023
0
8